DNA Synthesis Market projected to reach USD 10.5 Billion by 2030, growing at a CAGR of 18.5% during the forecast period of 2023-2030 – claims by MarketDigits in its recent study

The Global DNA Synthesis Market was valued USD 3.2 Billion in 2023 and projected to reach USD 10.5 Billion by 2030, growing at a CAGR of 18.5% during the forecast period of 2023-2030

Richmond, Dec. 08, 2023 (GLOBE NEWSWIRE) — According to a research report DNA Synthesis Market, by Service Type (Oligonucleotide Synthesis {Universal Oligonucleotide Synthesis, Custom Oligonucleotide Synthesis}, Gene Synthesis (Custom Gene Synthesis, Gene Library Synthesis), Application (Research and Development, Academic Applications, Industrial Applications, Diagnosis, Therapeutics), End User (Biopharmaceutical Companies, Academic and Research Institutes, Contract Research Organizations), and Region – Global Forecast to 2030″.

Global DNA Synthesis Market Report Scope:

Report Details
Market size value in 2023 USD 3.2 Billion
Market size value in 2030 USD 10.5 Billion
CAGR (2023-2030) 18.5%
Forecast Period 2023–2030
Historic Data 2019
Forecast Units Value (USD Million/USD Billion)
Segments Covered Service Type, Application, End User and Region
Geographies Covered North America, Europe, Asia Pacific, and RoW
  • Brooks Automation, Inc. (GENEWIZ)
  • Boster Biological Technology
Sample of Companies Covered
  • ProteoGenix
  • Biomatik
  • ProMab Biotechnologies, Inc

Download the Samplehttps://www.marketdigits.com/request/sample/3143

TOC Covers in Depth & Breath on DNA Synthesis Market
170 – Market Data Tables
65 – List of Figures
225 – Pages

The report includes Vendor Assessment (Company Profiles, Market Positioning, Strategies, Recent Developments, Capabilities & Product Offerings / Mapping), Technology Assessment (Developments & Economic Impact), Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional FootPrint by MarketDigits.

Market Overview

The DNA synthesis market refers to the industry involved in the production and commercialization of synthetic DNA, which involves the creation of custom-designed DNA sequences through chemical methods. The DNA synthesis market is experiencing robust growth, driven by the increasing demand for synthetic biology applications and advancements in genomics research. As of the latest assessments, the market is characterized by a myriad of key players, including industry leaders such as Thermo Fisher Scientific, Inc, Integrated DNA Technologies, Inc, and OriGene Technologies, Inc, as well as niche providers like GENEWIZ, Boster Biological Technology, ProteoGenix, and Biomatik. These companies contribute significantly to the expansion of the market, offering a wide range of DNA synthesis services and products. A pivotal factor propelling market growth is the escalating adoption of synthetic biology techniques across diverse sectors, including pharmaceuticals, agriculture, and bioenergy. DNA synthesis plays a pivotal role in designing and constructing synthetic genes, enabling researchers to engineer biological systems for various applications. Moreover, the continuous advancements in DNA synthesis technologies, such as high-throughput methods and automated platforms, enhance efficiency and reduce costs, further fostering market expansion.

Major Vendors in the Global DNA Synthesis Market:

  • Brooks Automation, Inc. (GENEWIZ)
  • Boster Biological Technology
  • ProteoGenix
  • Biomatik
  • ProMab Biotechnologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • Integrated DNA Technologies, Inc.
  • OriGene Technologies, Inc.

Request for Discount @ https://www.marketdigits.com/request/discount/3143

Increasing Demand in Synthetic Biology

The escalating demand in synthetic biology stands as a pivotal driver propelling the DNA synthesis market into a phase of robust growth and innovation. Synthetic biology, an interdisciplinary field that combines biology and engineering principles to design and construct new biological entities or redesign existing ones, relies heavily on the precise manipulation of genetic material. As researchers delve into groundbreaking applications such as gene editing, metabolic engineering, and the creation of synthetic organisms, the need for custom-designed DNA sequences becomes paramount. DNA synthesis plays a central role in fulfilling this demand, offering the capability to construct bespoke DNA fragments tailored to specific genetic designs. The convergence of synthetic biology and DNA synthesis opens avenues for advancements in diverse sectors, including medicine, agriculture, and industrial biotechnology. In medicine, the synthesis of custom DNA sequences facilitates the development of novel gene therapies and personalized medicine approaches. In agriculture, synthetic biology applications contribute to the creation of genetically modified organisms with enhanced traits for improved crop yields and pest resistance. The collaborative synergy between synthetic biology and DNA synthesis exemplifies a symbiotic relationship, with the increasing demand for one propelling the growth and sophistication of the other, thereby shaping the landscape of biotechnological advancements.

Market Dynamics


  • Increasing Demand in Synthetic Biology
  • Rise in Personalized Medicine


  • Rising investments towards research and development(R&D) activities
  • Demand for DNA Vaccines

Rising investments towards research and development (R&D) activities

The burgeoning opportunities within the DNA synthesis market are further accentuated by the upward trajectory of investments in research and development (R&D) activities. As the biotechnology and life sciences sectors witness a surge in interest and demand for innovative solutions, increased funding towards R&D becomes a catalyst for market expansion. These investments empower companies in the DNA synthesis space to explore cutting-edge technologies, refine existing processes, and drive advancements in genetic engineering and synthetic biology. The financial backing directed towards R&D initiatives enables the development of state-of-the-art platforms, automation technologies, and novel methodologies, enhancing the efficiency and capabilities of DNA synthesis. Moreover, it fosters the exploration of emerging applications and potential breakthroughs, positioning the DNA synthesis market at the forefront of transformative advancements. This emphasis on research not only fuels the current momentum but also lays the foundation for future discoveries, solidifying the market’s role in driving innovation across diverse scientific and industrial domains.

The market for DNA Synthesis is dominated by North America.

North America stands as the dominating region in the DNA Synthesis Market, exemplifying a robust stronghold characterized by technological prowess, extensive research infrastructure, and a burgeoning biotechnology landscape. The region’s dominance is underscored by the presence of key industry players, cutting-edge research institutions, and a proactive regulatory environment fostering innovation. The United States, in particular, serves as a nucleus for DNA synthesis advancements, driven by substantial investments in research and development. The region’s leadership is further emphasized by a heightened demand for synthetic biology applications across various sectors, ranging from pharmaceuticals to agriculture. With a mature biotechnology ecosystem and a culture of fostering scientific breakthroughs, North America continues to spearhead the evolution of the DNA synthesis market, positioning itself as a global leader in shaping the future of genetic engineering and molecular biology.

The Biopharmaceutical companies Segment is Anticipated to Hold the Largest Market Share During the Forecast Period

Based on end user the DNA synthesis market is segmented into biopharmaceutical companies, academic and research institutes, contract research organizations. Biopharmaceutical companies emerge as the dominant end-users in the DNA Synthesis Market, wielding a significant influence on the industry’s trajectory. Their dominance is anchored in the pivotal role DNA synthesis plays in drug discovery, development, and manufacturing within the biopharmaceutical sector. Custom-designed DNA sequences are indispensable for the creation of therapeutic proteins, monoclonal antibodies, and other biologics. Biopharmaceutical firms leverage DNA synthesis to engineer specific genetic constructs, enabling the production of novel biopharmaceuticals with enhanced efficacy and reduced side effects. The robust demand from these companies is fueled by a relentless pursuit of innovative therapies, personalized medicine, and advancements in precision medicine. As the biopharmaceutical landscape continues to evolve, the reliance on DNA synthesis for tailored solutions positions these companies as key drivers in shaping the future of the DNA Synthesis Market, where their needs and advancements steer the direction of technological developments and market growth.

Inquire Before Buying: https://www.marketdigits.com/request/enquiry-before-buying/3143

Browse Similar Reports:

DNA Polymerase Market 2030 By Type, Distribution Channel, End-user and Region – Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits

Plasmid DNA Manufacturing Market 2030 By Type, Distribution Channel, End-user and Region – Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits

Recombinant DNA Technology Market 2030 By Type, Distribution Channel, End-user and Region – Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits

About MarketDigits:

MarketDigits is one of the leading business research and consulting companies that helps clients to tap new and emerging opportunities and revenue areas, thereby assisting them in operational and strategic decision-making. We at MarketDigits believe that a market is a small place and an interface between the supplier and the consumer, thus our focus remains mainly on business research that includes the entire value chain and not only the markets.

We offer services that are most relevant and beneficial to the users, which help businesses to sustain themselves in this competitive market. Our detailed and in-depth analysis of the markets catering to strategic, tactical, and operational data analysis & reporting needs of various industries utilize advanced technology so that our clients get better insights into the markets and identify lucrative opportunities and areas of incremental revenues.

Contact Us:
1248 CarMia Way Richmond,
VA 23235,
United States.
USA: +1 847 450 0808
Email: sales@marketdigits.com
Web: https://www.marketdigits.com

Follow Us on: | Twitter | LinkedIn |

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaShorts takes no editorial responsibility for the same.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Privacy & Cookies Policy